Zhou; Liying

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhou; Liying.The latest application filed is for "method for treating endometriosis-associated pain by using diaminopyrimidine compound".

Company Profile

7.7.15

Zhou; Liying - Beijing CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Receptor inhibitor, pharmaceutical composition comprising same, and use thereof Grant 11,453,690 - Zhao , et al. September 27, 2	2022-09-27
P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof Grant 11,414,444 - Zhao , et al. August 16, 2	2022-08-16
Method For Treating Endometriosis-associated Pain By Using Diaminopyrimidine Compound App 20220249478 - ZHAO; Yanping ; et al.	2022-08-11
Method For Treating Idiopathic Pulmonary Fibrosis App 20220233538 - ZHAO; Yanping ; et al.	2022-07-28
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof Grant 11,390,609 - Zhao , et al. July 19, 2	2022-07-19
Method For Treating Cough By Using Diaminopyrimidine Compound App 20220211703 - ZHAO; Yanping ; et al.	2022-07-07
Solid Form Of Diaminopyrimidine Compound Or Hydrate Thereof, Preparation Method Therefor, And Application Thereof App 20220204475 - CHENG; CheungLing ; et al.	2022-06-30
Salt Of Diaminopyrimidine Compounds, And Solid Form Thereof, Preparation Method Therefor And Use Thereof App 20220177447 - ZHAO; Yanping ; et al.	2022-06-09
Double-stranded RNA Molecule Targeting CKIP-1 and Use Thereof App 20220064645 - ZHAO; Yanping ; et al.	2022-03-03
Rho-associated Protein Kinase Inhibitor, Pharmaceutical Composition Comprising Same, And Use Thereof App 20220002266 - ZHAO; Yanping ; et al.	2022-01-06
Receptor Inhibitors, Pharmaceutical Compositions Comprising The Same And Use Thereof App 20210395231 - ZHAO; Yanping ; et al.	2021-12-23
Pregabalin Sustained Release Composition And Method For Preparing The Same App 20210369621 - Zhu; Zhaolu ; et al.	2021-12-02
Double-stranded RNA molecule targeting CKIP-1 and use thereof Grant 11,155,819 - Zhao , et al. October 26, 2	2021-10-26
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof Grant 11,130,749 - Zhao , et al. September 28, 2	2021-09-28
P2x3 And/or P2x2/3 Receptor Antagonist, Pharmaceutical Composition Comprising Same, And Use Thereof App 20210179648 - ZHAO; Yanping ; et al.	2021-06-17
Receptor Inhibitor, Pharmaceutical Composition Comprising Same, And Use Thereof App 20210054007 - ZHAO; Yanping ; et al.	2021-02-25
Double-stranded RNA Molecule Targeting CKIP-1 and Use Thereof App 20200231967 - ZHAO; Yanping ; et al.	2020-07-23
Rho-associated Protein Kinase Inhibitor, Pharmaceutical Composition Comprising Same, And Preparation Method And Use Thereof App 20190276440 - ZHAO; Yanping ; et al.	2019-09-12
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof Grant 10,329,282 - Zhao , et al.	2019-06-25
Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof Grant 10,323,023 - Zhao , et al.	2019-06-18
Rho-associated Protein Kinase Inhibitor, Pharmaceutical Composition Comprising The Same, As Well As Preparation Method And Use Thereof App 20190010143 - ZHAO; Yanping ; et al.	2019-01-10
Rho-associated Protein Kinase Inhibitor, Pharmaceutical Composition Comprising The Same, As Well As Preparation Method And Use Thereof App 20190002442 - ZHAO; Yanping ; et al.	2019-01-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.